投資有価証券売却益、Impairment LossEL - Chemistry Reportable Segments Member、Net IncomeSE他1件
- 【期間】
年度 | 投資有価証券売却益 | Impairment LossEL - Chemistry Reportable Segments Member | Net IncomeSE | Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Engineering Reportable Segment Member |
---|
2013/12 | 446億 | | - | | - | | - | |
2014/12 | 61.4億 | -86.2% | - | | - | | - | |
2017/12 | 246億 | +300.3% | - | | - | | - | |
2018/12 | 303億 | +23.5% | - | | - | | - | |